Guillaume Le Guenno

7PUBLICATIONS
68CO-AUTHORS
Innate immunityHaematological tumoursAutoimmunityRespiratory diseasesOptical technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 29, 2025
Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndrome.

Paul Breillat, Francesco Carbone, Emilie Lereclus

|May 15, 2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX.

Vincent Jachiet, Olivier Kosmider, Maxime Beydon

|Jan 30, 2024
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation.

|Aug 25, 2023
Treatment strategy for acquired pure red cell aplasia: a systematic review and meta-analysis.

Hervé Lobbes, Jean-Christophe Lega, Guillaume Le Guenno

|May 24, 2022
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study.

Maël Heiblig, Marcela A Ferrada, Matthew J Koster

|Nov 08, 2019
Computed and Subjective Blue Scleral Color Analysis as a Diagnostic Tool for Iron Deficiency: A Pilot Study.

Hervé Lobbes, Julien Dehos, Bruno Pereira

Pageof 2

Frequent Collaborators

3 joint publications

Roderau Outh

3 joint publications

Olivier Kosmider

2 joint publications

Hervé Lobbes

2 joint publications

Léa Dionet